Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch + Lomb Corporation Common Shares (NY:BLCO)

15.63 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Oct 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 15.63
Bid (Size) 15.38 (15)
Ask (Size) 16.00 (1)
Prev. Close 15.63
Today's Range 15.63 - 15.63
52wk Range 10.45 - 20.94
Shares Outstanding 353,700,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know
Shares of eyecare company Bausch + Lomb (NYSE:BLCO) jumped 3.1% in the morning session after reports revealed an activist investor, Jana Partners, took a stake in competitor Cooper Companies and was... 
Via StockStory
Topics Initial Public Offering World Trade
Activist Investor Turns Up Heat On Cooper, Urges Bausch + Lomb Merger To Boost Returns: Report
Jana Partners is urging Cooper to improve capital use and returns, saying its contact-lens and women’s health units lack strategic fit and drag on performance. 
Via Stocktwits

Performance

YTD
-13.2%
-13.2%
1 Month
+2.5%
+2.5%
3 Month
+9.3%
+9.3%
6 Month
+25.1%
+25.1%
1 Year
-24.4%
-24.4%

More News

Read More
3 Stocks Under $50 We Steer Clear Of
Via StockStory
Topics Economy Supply Chain
3 Unpopular Stocks Walking a Fine Line
Via StockStory
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13
From Bausch + Lomb Corporation
Via Business Wire
1 Small-Cap Stock to Keep an Eye On and 2 That Underwhelm
Via StockStory
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Bausch + Lomb Announces Publication of enVista Envy™ Full Range of Vision Intraocular Lens Pivotal U.S. Clinical Trial
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens Wearers
From Bausch + Lomb Corporation
Via Business Wire
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why
Via StockStory
Topics Economy Initial Public Offering Stocks
Bausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United States
From Bausch + Lomb Corporation
Via Business Wire
3 Healthcare Stocks Walking a Fine Line
Via StockStory
Topics Stocks
Bausch + Lomb (BLCO) Stock Is Up, What You Need To Know
Via StockStory
Topics Economy Initial Public Offering Stocks
Purple, Bausch + Lomb, Etsy, Intel, and Camping World Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Stocks
Medical Devices & Supplies - Specialty Stocks Q2 Highlights: Bausch + Lomb (NYSE:BLCO)
Via StockStory
Bausch + Lomb Announces Board Changes
From Bausch + Lomb Corporation
Via Business Wire
1 Safe-and-Steady Stock with Competitive Advantages and 2 That Underwhelm
Via StockStory
Bausch + Lomb to Participate in Upcoming Investor Conferences
From Bausch + Lomb Corporation
Via Business Wire
Sotera Health Company, Incyte, Exact Sciences, Bausch + Lomb, and Addus HomeCare Shares Skyrocket, What You Need To Know
Via StockStory
Topics Economy Lawsuit
BLCO Q2 Deep Dive: Product Launches Offset Margin Pressures, Management Highlights Pipeline Investments
Via StockStory
1 Stock Under $50 to Target This Week and 2 We Ignore
Via StockStory
3 Small-Cap Stocks with Warning Signs
Via StockStory
Bausch Lomb (BLCO) Q2 Revenue Rises 5%
Via The Motley Fool
Why Bausch + Lomb (BLCO) Stock Is Down Today
Via StockStory
Topics Artificial Intelligence Initial Public Offering
Bausch + Lomb’s (NYSE:BLCO) Q2 Sales Top Estimates, Full-Year Outlook Slightly Exceeds Expectations
Via StockStory

Frequently Asked Questions

Is Bausch + Lomb Corporation Common Shares publicly traded?
Yes, Bausch + Lomb Corporation Common Shares is publicly traded.
What exchange does Bausch + Lomb Corporation Common Shares trade on?
Bausch + Lomb Corporation Common Shares trades on the New York Stock Exchange
What is the ticker symbol for Bausch + Lomb Corporation Common Shares?
The ticker symbol for Bausch + Lomb Corporation Common Shares is BLCO on the New York Stock Exchange
What is the current price of Bausch + Lomb Corporation Common Shares?
The current price of Bausch + Lomb Corporation Common Shares is 15.63
When was Bausch + Lomb Corporation Common Shares last traded?
The last trade of Bausch + Lomb Corporation Common Shares was at 10/21/25 07:00 PM ET
What is the market capitalization of Bausch + Lomb Corporation Common Shares?
The market capitalization of Bausch + Lomb Corporation Common Shares is 5.53B
How many shares of Bausch + Lomb Corporation Common Shares are outstanding?
Bausch + Lomb Corporation Common Shares has 6B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.